Genzyme Recognizes Rare Disease Day by Launching New Program

Genzyme Corporation has launched a new program to recognize International Rare Disease Day.

February 28, 2011 marks the fourth International Rare Disease Day, created by the patient organization EURORDIS and involving rare disease organizations globally. This year's theme is "Rare but Equal".

Genzyme Corporation has launched a new program, the Genzyme Patient Advocacy Leadership Awards, to recognize International Rare Disease Day. A global grant program, the Genzyme PAL Awards will support non-profit organizations that work on behalf of patients living with lysosomal storage disorders (LSDs), a group of rare, inherited disorders that cause progressive and debilitating health problems. A total of $50,000 will be awarded through a competitive application process to organizations that seek funding for new initiatives that support the LSD patient community.